Chinese Journal of Stroke ›› 2023, Vol. 18 ›› Issue (07): 829-836.DOI: 10.3969/j.issn.1673-5765.2023.07.014
Previous Articles Next Articles
LI Ping, FU Shengqi
Received:
2023-01-29
Online:
2023-07-20
Published:
2023-07-20
李萍,付胜奇
作者简介:
付胜奇 shengqifu@126.com
基金资助:
LI Ping, FU Shengqi. Research Progress on the Role of Sphingosine 1-Phosphate in Ischemic Stroke[J]. Chinese Journal of Stroke, 2023, 18(07): 829-836.
李萍, 付胜奇. 1-磷酸鞘氨醇在缺血性卒中中的作用研究进展[J]. 中国卒中杂志, 2023, 18(07): 829-836.
[1] FESKE S K. Ischemic stroke[J]. Am J Med,2021,134(12):1457-1464. [2] SHI K,TIAN D C,LI Z G,et al. Global brain inflammation in stroke[J]. Lancet Neurol,2019,18(11):1058-1066. [3] LAWSON T R,BROWN I E,WESTERKAM D L,et al. Tissue plasminogen activator(rt-PA)in acute ischemic stroke:outcomes associated with ambulation[J]. Restor Neurol Neurosci,2015,33(3):301-308. [4] MORALES-RUIZ M,LEE M J,ZÖLLNER S,et al. Sphingosine 1-phosphate activates Akt,nitric oxide production,and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells[J]. J Biol Chem,2001,276(22):19672-19677. [5] LIU J,SUGIMOTO K,CAO Y B,et al. Serum sphingosine 1-phosphate(S1P):a novel diagnostic biomarker in early acute ischemic stroke[J/OL]. Front Neurol,2020,11:985[2022-12-11]. https://doi.org/10.3389/fneur.2020.00985. [6] LU S S,SHE M H,ZENG Q,et al. Sphingosine 1-phosphate and its receptors in ischemia[J/OL]. Clin Chim Acta,2021,521:25-33[2022-12-11]. https://doi.org/10.1016/j.cca.2021.06.020. [7] PITSON S M. Regulation of sphingosine kinase and sphingolipid signaling[J]. Trends Biochem Sci,2011,36(2):97-107. [8] OBINATA H,HLA T. Sphingosine 1-phosphate and inflammation[J]. Int Immunol,2019,31(9):617-625. [9 MARTIN R,SOSPEDRA M. Sphingosine-1 phosphate and central nervous system[J/OL]. Curr Top Microbiol Immunol,2014,378:149-170[2022-12-11]. https://doi.org/10.1007/978-3-319-05879-57. [10] OSINDE M,MULLERSHAUSEN F,DEV K K. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors[J]. Neuropharmacology,2007,52(5):1210-1218. [11] GAIRE B P,CHOI J W. Sphingosine 1-phosphate receptors in cerebral ischemia[J]. Neuromolecular Med,2021,23(1):211-223. [12] ZHANG L,WANG H D. FTY720 in CNS injuries:molecular mechanisms and therapeutic potential[J/OL]. Brain Res Bull,2020,164:75-82[2022-12-11]. https://doi.org/10.1016/j.brainresbull.2020.08.013. [13] ZHANG S Q,XIAO J,CHEN M,et al. Sphingosine-1-phosphate signaling in ischemic stroke:from bench to bedside and beyond[J/OL]. Front Cell Neurosci,2021,15:781098[2022-12-11]. https://doi.org/10.3389/fncel.2021.781098. [14] GAIRE B P,BAE Y J,CHOI J W. S1P1 regulates M1/M2 polarization toward brain injury after transient focal cerebral ischemia[J]. Biomol Ther(Seoul),2019,27(6):522-529. [15] SAPKOTA A,GAIRE B P,KANG M G,et al. S1P2 contributes to microglial activation and M1 polarization following cerebral ischemia through ERK1/2 and JNK[J/OL]. Sci Rep,2019,9(1):12106[2022-12-11]. https://doi.org/10.1038/s41598-019-48609-z. [16] GAIRE B P,SONG M R,CHOI J W. Sphingosine 1-phosphate receptor subtype 3(S1P3)contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization[J/OL]. J Neuroinflammation,2018,15(1):284[2022-12-11]. https://doi.org/10.1186/s12974-018-1323-1 [17] ZHAO Y F,ZHANG X J,CHEN X Y,et al. Neuronal injuries in cerebral infarction and ischemic stroke:from mechanisms to treatment(review)[J/OL]. Int J Mol Med,2022,49(2):15[2022-12-11]. https://doi.org/10.3892/ijmm.2021.5070. [18] SUN L L,ZHANG Y X,LIU E,et al. The roles of astrocyte in the brain pathologies following ischemic stroke[J]. Brain Inj,2019,33(6):712-716. [19] COLOMBO E,BASSANI C,DE ANGELIS A,et al. Siponimod(BAF312)activates Nrf2 while hampering NFkappaB in human astrocytes,and protects from astrocyte-induced neurodegeneration[J/OL]. Front Immunol,2020,11:635[2022-12-11]. https://doi.org/10.3389/fimmu.2020.00635. [20] XU S B,LU J N,SHAO A W,et al. Glial cells:role of the immune response in ischemic stroke[J/OL]. Front Immunol,2020,11:294[2022-12-11]. https://doi.org/10.3389/fimmu.2020.00294. [21] LI Y J,SHI S X,LIU Q,et al. Targeted role for sphingosine-1-phosphate receptor 1 in cerebrovascular integrity and inflammation during acute ischemic stroke[J/OL]. Neurosci Lett,2020,735:135160[2022-12-11]. https://doi.org/10.1016/j.neulet.2020.135160. [22] JUNG B,OBINATA H,GALVANI S,et al. Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development[J]. Dev Cell,2012,23(3):600-610. [23] ICHIJO M,ISHIBASHI S,LI F Y,et al. Sphingosine-1-phosphate receptor-1 selective agonist enhances collateral growth and protects against subsequent stroke[J/OL]. PLoS One,2015,10(9):e0138029[2022-11-22]. https://doi.org/10.1371/journal.pone.0138029. [24] IWASAWA E,ISHIBASHI S,SUZUKI M,et al. Sphingosine-1-phosphate receptor 1 activation enhances leptomeningeal collateral development and improves outcome after stroke in mice[J]. J Stroke Cerebrovasc Dis,2018,27(5):1237-1251. [25] BLUM A,VAISPAPIR V,KEINAN-BOKER L,et al. Endothelial dysfunction and procoagulant activity in acute ischemic stroke[J]. J Vasc Interv Neurol,2012,5(1):33-39. [26] YANAGIDA K,LIU C H,FARACO G,et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1[J]. Proc Natl Acad Sci U S A,2017,114(17):4531-4536. [27] SANCHEZ T. Sphingosine-1-phosphate signaling in endothelial disorders[J/OL]. Curr Atheroscler Rep,2016,18(6):31[2022-12-11]. https://doi.org/10.3892/ijmm.2021.5070. [28] CAO C C,DAI L,MU J Y,et al. S1PR2 antagonist alleviates oxidative stress-enhanced brain endothelial permeability by attenuating p38 and Erk1/2-dependent cPLA2 phosphorylation[J/OL]. Cell Signal,2019,53:151-161[2022-12-11]. https://doi.org/10.1016/j.cellsig.2018.09.019. [29] NITZSCHE A,POITTEVIN M,BENARAB A,et al. Endothelial S1P1 signaling counteracts infarct expansion in ischemic stroke[J]. Circ Res,2021,128(3):363-382. [30] YANG C J,HAWKINS K E,DORE S,et al. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke[J/OL]. Am J Physiol Cell Physiol,2019,316(2):C135-C153[2022-12-11]. https://doi.org/10.1152/ajpcell.00136.2018. [31] PROFACI C P,MUNJI R N,PULIDO R S,et al. The blood-brain barrier in health and disease:important unanswered questions[J/OL]. J Exp Med,2020,217(4):e20190062[2022-12-11]. https://doi.org/10.1084/jem.20190062. [32] NAKAGAWA S,ARUGA J. Sphingosine 1-phosphate signaling is involved in impaired blood-brain barrier function in ischemia-reperfusion injury[J]. Mol Neurobiol,2020,57(3):1594-1606. [33] XIANG P,CHEW W S,SEOW W L,et al. The S1P2 receptor regulates blood-brain barrier integrity and leukocyte extravasation with implications for neurodegenerative disease[J/OL]. Neurochem Int,2021,146:105018[2022-12-11]. https://doi.org/10.1016/j.neuint.2021.105018. [34] ZHU Z L,FU Y,TIAN D C,et al. Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke:a pilot trial[J]. Circulation,2015,132(12):1104-1112. [35] POIRIER B,BRIAND V,KADEREIT D,et al. A G protein-biased S1P1 agonist,SAR247799,protects endothelial cells without affecting lymphocyte numbers[J/OL]. Sci Signal,2020,13(634):eaax8050[2022-12-11]. https://doi.org/10.1126/scisignal.aax8050. [36] HASEGAWA Y,SUZUKI H,SOZEN T,et al. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats[J]. Stroke,2010,41(2):368-374. [37] VOGELGESANG A,DOMANSKA G,RUHNAU J,et al. Siponimod(BAF312)treatment reduces brain infiltration but not lesion volume in middle-aged mice in experimental stroke[J]. Stroke,2019,50(5):1224-1231. [38] LEE T H,CHENG C N,CHAO H C,et al. Plasma ceramides are associated with outcomes in acute ischemic stroke patients[J/OL]. J Formos Med Assoc,2022,121(1 Pt 1):43-50[2022-12-11]. https://doi.org/10.1016/j.jfma.2021.01.006. [39] SCHWEDHELM E,SCHWIEREN L,TIEDT S,et al. Serum sphingosine-1-phosphate levels are associated with severity and outcome in patients with cerebral ischemia[J]. Stroke,2021,52(12):3901-3907. [40] CZECH B,PFEILSCHIFTER W,MAZAHERI-OMRANI N,et al. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia[J]. Biochem Biophys Res Commun,2009,389(2):251-256. |
[1] | GU Hongqiu, YANG Kaixuan, JIANG Yingyu, DU Kejin, RAO Zhenzhen, YANG Xin, WANG Chunjuan, XIONG Yunyun, JING Jing, LI Zixiao. Progress and Prospects of Clinical Prediction Models for Risk of Stroke Recurrence in Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(07): 731-739. |
[2] | CHEN Siding, JIANG Yong, XU Zhe, SHI Yanfeng, CHENG Si, GU Hongqiu, WANG Yongjun. Construction and Application of Polygenic Risk Score in Stroke [J]. Chinese Journal of Stroke, 2023, 18(07): 741-750. |
[3] | WANG Yan, LI Jiashu, FANG Ruile, LIU Gaifen, JU Yi. Influencing Factors of Anxiety and Depression State at 6 months after Stroke in Acute Mild Stroke Patients with Vestibular Symptoms [J]. Chinese Journal of Stroke, 2023, 18(07): 787-792. |
[4] | WANG Yao, QIN Haiqiang, WANG Anxin, ZHANG Xiaoli, ZUO Yingting, ZHANG Yaqing, YANG Bo, YU Dandan, WEI Na, ZHANG Jing. Relationship between Body Mass Index and 3-Month Prognosis of Stroke Patients [J]. Chinese Journal of Stroke, 2023, 18(07): 793-798. |
[5] | LOU Min, DING Jing, ZHANG Yusheng, HU Bo, WAN Yan, ZHANG Kemeng, FEI Beini, XU Bingdong, TAN Zefeng, XU Anding, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases. Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition)(Excerpt)—Chapter Two Stroke Organized Management [J]. Chinese Journal of Stroke, 2023, 18(07): 822-828. |
[6] | CHENG Yaqin, WEN Chundi, CHEN Xiaona, CHEN Yanjun, CHEN Xingxing. Meta-analysis of the Effect of Task-oriented Training on Balance Function Rehabilitation in Patients after Stroke [J]. Chinese Journal of Stroke, 2023, 18(06): 660-669. |
[7] | FANG Ruile, LENG Qi, JU Yi. Comparison of the Risk Factors, Clinical Manifestations and Imaging Characteristics of Patients with Ischemic Stroke caused by Vertebral Artery Dissection in Young and Middle-senile Group [J]. Chinese Journal of Stroke, 2023, 18(06): 670-676. |
[8] | ZHANG Yingfang, YE min, SHANG Yu, WU Mingfeng. Clinical Value of Serum TIMP-3 in Predicting Death in Patients with Malignant Middle Cerebral Artery Infarction [J]. Chinese Journal of Stroke, 2023, 18(06): 677-683. |
[9] | LU Qingli, WU Songdi. Retinal Artery Occlusion: Knowledge and Challenge of “Retinal Stroke” [J]. Chinese Journal of Stroke, 2023, 18(06): 712-719. |
[10] |
HUANG Zhencan, ZHANG Ya’nan, SUN Qingqing, WU Xiaodan, WANG Zan.
Study of Biomarkers of Stroke with Obstructive Sleep Apnea Syndrome
[J]. Chinese Journal of Stroke, 2023, 18(05): 514-519.
|
[11] |
JIA Hui, WANG Di, SUO Rui, WEI Xinya, ZHU Yulan.
Research Advances on Mechanisms of Increased Stroke Risk by Circadian Rhythm Disruption
[J]. Chinese Journal of Stroke, 2023, 18(05): 520-526.
|
[12] |
YANG Hangmei, HAN Meirong, JIANG Xuelong, HE Zhongming, HAN Fang.
Research Progress of Insomnia after Stroke
[J]. Chinese Journal of Stroke, 2023, 18(05): 527-533.
|
[13] |
GUO Zhenni, ZHANG Han, FU Yuli, WANG Zan, YANG Yi, DENG Fang.
Application of Problem-based Learning Combined with Virtual Reality Technology in Clinical Teaching of Post-stroke Sleep Disorder
[J]. Chinese Journal of Stroke, 2023, 18(05): 534-537.
|
[14] |
CHEN Hui, CHEN Siding, ZHU Zhikai, YU Weiran, JIANG Yong, WANG Yongjun.
Study on Predictive Model of Cerebral Hemorrhage during Hospitalization in Patients with Acute Ischemic Stroke Treated with rt-PA Intravenous Thrombolysis
[J]. Chinese Journal of Stroke, 2023, 18(05): 547-555.
|
[15] |
LIAO Yuqi, CAO Liming, REN Lijie.
Research Progress of Current Status for Pre-hospital Delay and Improvement Measures for Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2023, 18(05): 594-600.
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||